Drugs. Prescription for conflict.
Swindon PCT must review its exceptional circumstances procedures as a result of the Ann Marie Rogers ruling. The PCT lost the case because it had not considered cost in reaching its decision. PCTs are advised not to have blanket policies on drug funding--exceptions should always be allowed for.
Moore
Alison
A
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000178:diet therapy; D005260:Female; D006779:Hospitals, Public / Q000331:legislation & jurisprudence*; D006801:Humans; D016079:Refusal to Treat / Q000331:legislation & jurisprudence*; D013222:State Medicine; D000068878:Trastuzumab; D006113:United Kingdom
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab